Arena Pharmaceuticals (ARNA) Posts Mixed Q1 Results
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Price: $7.98 -0.25%
Financial Fact:
Collaborative agreements: 1.61M
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Collaborative agreements: 1.61M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.92 million versus the consensus estimate of $3.29 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
- Tri-Tech Holdings, Inc. (TRIT) Swings to Q1 Loss
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
